Free Trial

Verona Pharma (VRNA) SEC Filings & 10K Form

Verona Pharma logo
$53.84 -4.25 (-7.32%)
As of 10:29 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Verona Pharma SEC Filings

DateFilerForm TypeView
03/28/2025
6:08 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
3:34 PM
Verona Pharma (Filer)
Form ARS
03/13/2025
7:15 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:31 PM
Verona Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
7:46 AM
Verona Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
5:07 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:43 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Verona Pharma (Subject)
Form SCHEDULE 13G/A
02/04/2025
3:30 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
7:33 PM
Growth Equity Opportunities Fund IV, LLC (Filed by)
Verona Pharma (Subject)
Form SCHEDULE 13D/A
01/07/2025
5:00 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
4:50 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:51 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
6:19 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
6:20 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
5:35 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
5:36 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
5:34 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:42 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
3:20 PM
EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Verona Pharma (Subject)
Form SC 13G/A
11/14/2024
3:50 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Verona Pharma (Subject)
Form SC 13G/A
11/14/2024
3:31 PM
Verona Pharma (Subject)
Form SC 13G
11/14/2024
8:47 AM
Deep Track Capital, LP (Filed by)
Verona Pharma (Subject)
Form SC 13G/A
11/13/2024
7:46 PM
Verona Pharma (Subject)
VIVO VENTURES VII, LLC (Filed by)
Form SC 13G/A
11/13/2024
3:57 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
9:34 AM
FMR LLC (Filed by)
Verona Pharma (Subject)
Form SC 13G/A
11/07/2024
5:56 PM
ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
5:57 PM
EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:40 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:41 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
7:47 AM
Verona Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
5:06 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
6:19 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
6:13 PM
Fisher Andrew (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
6:14 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
6:17 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
6:55 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
6:54 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
7:45 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
7:46 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:20 PM
Verona Pharma (Subject)
ZACCARDELLI DAVID (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Feds Just Admitted It—They Can Take Your Cash (Ad)

The Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money isn't legally yours. Now, think your savings are safe? Think again.

Click here to get the 3 secret strategies you can put in place starting today
10/18/2024
3:20 PM
Hahn Mark W (Reporting)
Verona Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:22 PM
Verona Pharma (Subject)
ZACCARDELLI DAVID (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:22 PM
Hahn Mark W (Reporting)
Verona Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
8:51 PM
Growth Equity Opportunities Fund IV, LLC (Filed by)
Verona Pharma (Subject)
Form SC 13D/A
08/12/2024
3:20 PM
Hahn Mark W (Reporting)
Verona Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
3:20 PM
Verona Pharma (Subject)
ZACCARDELLI DAVID (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
6:11 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
6:12 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
6:13 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
7:44 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:51 AM
Verona Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2024
8:28 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
8:29 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
8:30 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2024
8:43 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Verona Pharma (Subject)
Form SC 13G
06/27/2024
5:02 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
7:53 AM
Verona Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/10/2024
8:09 AM
Verona Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:22 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:18 AM
Verona Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
6:19 PM
Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:21 PM
Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
6:23 PM
Hahn Mark W (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
3:15 PM
Brady James Aloysius (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
3:16 PM
Cunningham Kenneth (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
3:17 PM
SHAH MAHENDRA (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
3:17 PM
ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
3:17 PM
EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
3:17 PM
Ullman Anders (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
3:17 PM
Edwards Martin (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
3:18 PM
Sinha Vikas (Reporting)
Verona Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:VRNA) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners